Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: market exclusivity
EU Review of Pharmaceutical Incentives: Recommendations for Change
Ellen 't Hoen
-
June 3, 2019
Time to put a stop to the abuse of orphan drug...
Ellen 't Hoen
-
January 9, 2019
Dutch health insurance company Menzis takes AstraZeneca to court over patent...
Ellen 't Hoen
-
September 20, 2018
European Pharmaceutical Legislation Needs Exceptions to Data and Market Exclusivity to...
Ellen 't Hoen
-
May 21, 2018
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
This work is licensed under Creative Commons.